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Introduction
Commitment of a cell to develop along a prescribed pathway is 
thought to occur in two stages (Gilbert, 2006). The fi  rst stage, 
which is called specifi  cation, is characterized by the ability of a 
cell to differentiate autonomously in a neutral environment; how-
ever, the fate of the cell can still be redirected. During the deter-
mination phase, a cell will differentiate according to its prescribed 
fate even when placed in an environment that induces the develop-
ment of other tissue types. In this case, commitment is considered 
to be stable and irreversible under normal circumstances.
Previous studies suggested that commitment to the skeletal 
muscle lineage occurs in the somites in response to factors re-
leased by surrounding structures and those produced within the 
somites themselves (Buckingham and Tajbakhsh, 1999; Linker 
et al., 2003; for reviews see Borycki and Emerson, 2000; Stockdale 
et al., 2000; Pownall et al., 2002). Stable commitment was oper-
ationally defi  ned as the maintenance of myogenic potential when 
the muscle-forming region of the somite was exposed to factors 
that promote chondrogenesis (Watterson et al., 1954; Aoyama 
and Asamoto, 1988; Christ et al., 1992; Ordahl and Le Douarin, 
1992; Brand-Saberi et al., 1993; Pourquie et al., 1993; Bober et al., 
1994; Goulding et al., 1994; Dockter and Ordahl, 2000). At the 
molecular level, commitment is driven by up-regulation of the 
skeletal muscle–specifi  c transcription factors Myf5, MyoD, and 
Mrf4 in progenitor cells expressing the paired box transcription 
factors Pax-3 and/or Pax-7 (Sassoon et al., 1989; Ott et al., 1991; 
Pownall and Emerson, 1992; Rudnicki et al., 1993; Goulding 
et al., 1994; Williams and Ordahl, 1994; Marcelle et al., 1995; 
Maroto et al., 1997; Tajbakhsh et al., 1997; Kahane et al., 2001; 
Kassar-Duchossoy et al., 2004, 2005). Genetic manipulations of 
the mouse embryo revealed that Myf5 and Mrf4 are responsible 
for the initial activation of MyoD, whereas Pax-3 assumes this 
function later in development (Tajbakhsh et al., 1997; Kassar-
Duchossoy et al., 2004).
Analyses of the chick embryo have yielded confl  icting 
results regarding the sequence of expression of skeletal muscle 
transcription factors. In situ hybridization with enzymatic probes 
revealed that Myf5 but not MyoD was expressed in the pre-
somitic mesoderm (Maroto et al., 1997; Hacker and Guthrie, 
1998; Hirsinger et al., 2001; Kiefer and Hauschka, 2001). Low 
levels of Myf5 were detected in the primitive streak and adjacent 
epiblast of the stage 3 embryo (Kiefer and Hauschka, 2001). In 
contrast, in situ hybridization with fl  uorescent dendrimer probes 
and RT-PCR demonstrated the presence of MyoD mRNA in 
the presomitic mesoderm, stage 3 embryo, and stage 1 epiblast 
(George-Weinstein et al., 1996; Gerhart et al., 2000; Strony et al., 
2005). Given that epiblast cells expressing low levels of MyoD 
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he epiblast of the chick embryo contains cells that 
express MyoD mRNA but not MyoD protein. We 
investigated whether MyoD-positive (MyoD
pos) epi-
blast cells are stably committed to the skeletal muscle 
lineage or whether their fate can be altered in different 
environments. A small number of MyoD
pos epiblast cells 
were tracked into the heart and nervous system. In these 
locations, they expressed MyoD mRNA and some synthe-
sized MyoD protein. No MyoD
pos epiblast cells differenti-
ated into cardiac muscle or neurons. Similar results were 
obtained when MyoD
pos cells were isolated from the epi-
blast and microinjected into the precardiac mesoderm or 
neural plate. In contrast, epiblast cells lacking MyoD dif-
ferentiated according to their environment. These results 
demonstrate that the epiblast contains both multipotent 
cells and a subpopulation of cells that are stably commit-
ted to the skeletal muscle lineage before the onset of 
gastrulation. Stable programming in the epiblast may 
ensure that MyoD
pos cells express similar signaling mole-
cules in a variety of environments.
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mRNA represent a small subpopulation within the presomitic 
mesoderm and somites (Gerhart et al., 2000), it is possible that 
they were not clearly visible with enzymatic probes. These 
MyoD-positive (MyoD
pos) cells may correspond to the small 
subpopulation of presomitic mesoderm cells that are capable of 
differentiating in cultured explants of presomitic mesoderm tis-
sue (Stern and Hauschka, 1995; Stern et al., 1997).
The importance of MyoD expression in the epiblast of the 
chick embryo was demonstrated in vitro and in vivo. When epi-
blast cells that express MyoD mRNA were isolated from the 
embryo and cultured in serum-free medium, nearly all differ-
entiated into skeletal muscle (Gerhart et al., 2004a). In vivo, 
most MyoD
pos epiblast cells were incorporated into the somites 
and synthesized Noggin (Gerhart et al., 2006). Noggin pro-
motes skeletal muscle differentiation in the somites by block-
ing the bone morphogenetic protein (BMP) signaling pathway 
(Pourquie et al., 1996; Zimmerman et al., 1996; Hirsinger et al., 
1997; Marcelle et al., 1997; Dietrich et al., 1998; Reshef et al., 
1998; Tonegawa and Takahashi, 1998; Amthor et al., 1999; Sela-
Donenfeld and Kalcheim, 2002; Linker et al., 2003). Ablation 
of MyoD
pos cells in the epiblast resulted in a decrease in Noggin 
in the somites and a dramatic reduction in skeletal muscle in 
the trunk and limbs (Gerhart et al., 2006). The inhibition of mus-
cle differentiation after ablation was averted with the addition 
of exogenous Noggin. Thus, cells that express MyoD mRNA in 
the epiblast regulate skeletal myogenesis in the somites by re-
leasing Noggin.
The ability to differentiate in vitro and to promote muscle 
differentiation in vivo does not necessarily indicate that cells 
expressing MyoD mRNA in the epiblast are stably committed 
to the skeletal muscle lineage. Several studies have demon-
strated that skeletal muscle transcription factors are transiently 
expressed during the early stages of development. Myf5 and 
MyoD mRNAs were initially expressed in nonmyogenic tissues 
of the chick and Xenopus laevis embryo, respectively, and gradu-
ally became restricted to muscle-forming regions of the somite 
(Rupp and Weintraub, 1991; Steinbach et al., 1998; Kiefer and 
Hauschka, 2001). Separation of the somites from surrounding 
tissues resulted in a down-regulation of MyoD and Myf5 and 
a failure of cells to differentiate (Maroto et al., 1997; Borycki 
et al., 1998; Dietrich et al., 1998; Teillet et al., 1998; Reshef et al., 
1998; Marcelle et al., 1999; Pirskanen et al., 2000). Further-
more, some cells that express skeletal muscle transcription factors 
in adult muscle can be induced to differentiate into bone and 
adipocytes (for review see Chen and Goldhamer, 2003). These 
studies suggest that low levels of expression of skeletal muscle 
transcription factors may be the hallmark of specifi  cation but 
not of stable commitment to the skeletal muscle lineage. How-
ever, small numbers of cells in the presomitic mesoderm and 
myogenic precursors in the limb that have not up-regulated 
skeletal muscle–specifi   c transcription factors do undergo 
skeletal myogenesis even when challenged with cartilage-
promoting factors from the notochord (Williams and Ordahl, 
1997, 2000).
The following studies were designed to determine whether 
MyoD
pos epiblast cells are stably committed to the skeletal mus-
cle lineage or whether their fate can be altered in environments 
that induce the differentiation of nonskeletal muscle tissues. 
The environment of the developing heart is particularly chal-
lenging to skeletal myogenesis because BMPs are required for 
specifi  cation of the heart-forming fi  elds and cardiomyocyte 
differentiation (Lough et al., 1996; Schultheiss et al., 1997), 
but they inhibit skeletal muscle differentiation (Pourquie et al., 
1996; Hirsinger et al., 1997; Marcelle et al., 1997; Dietrich 
et al., 1998; Reshef et al., 1998; Tonegawa and Takahashi, 1998; 
Amthor et al., 1999; Sela-Donenfeld and Kalcheim, 2002; 
Linker et al., 2003). BMPs also play a role in the induction 
of dorsal cell fates in the neural tube (Basler et al., 1993; 
Dickinson et al., 1994; Liem et al., 1995; Hogan, 1996; Dudley 
and Robertson, 1997; Lee et al., 1998; Nguyen et al., 2000). 
Although BMP inhibitors are required for establishing ventral 
neuronal fates, neural tube closure, and anterior brain forma-
tion (McMahon et al., 1998; Bachiller et al., 2000; Hartley 
et al., 2001), skeletal muscle differentiation is not induced in 
the nervous system.
The state of commitment of MyoD
pos epiblast cells was 
examined in two ways. First, cells that express MyoD in the 
epiblast were tracked into the heart and nervous system. Sec-
ond, MyoD
pos cells were isolated from the epiblast and micro-
injected into the precardiac mesoderm and neural plate. In both 
types of experiments, MyoD
pos epiblast cells continued to ex-
press MyoD mRNA, some synthesized MyoD protein, and none 
differentiated into cardiac muscle or neurons. In contrast, cells 
that did not express MyoD in the epiblast differentiated accord-
ing to their location.
Results
Expression of MyoD protein and Myf5 
mRNA in the epiblast
MyoD mRNA is expressed in a small subpopulation of cells 
in the pregastrulating epiblast (George-Weinstein et al., 1996; 
Gerhart et al., 2000, 2006; Strony et al., 2005). To determine 
whether these cells produce MyoD protein, stage 1–4 embryos 
were double labeled with mAbs to MyoD and the G8 antigen. 
The G8 mAb binds to a cell surface antigen and is a specifi  c 
marker for cells that express MyoD mRNA in the epiblast 
(Fig. 1 A; Gerhart et al., 2001, 2004a; Strony et al., 2005). 
MyoD protein was not detected in stage 1 or 2 embryos, and 
only a single G8-positive (G8
pos) cell in the stage 4 epiblast 
was labeled with the MyoD antibody (Fig. 1, B–D). These 
results were confi  rmed with a rabbit polyclonal antiserum to 
MyoD. Therefore, MyoD mRNA either is not translated or 
the protein does not accumulate to detectable levels in the 
early epiblast.
MyoD
pos epiblast cells were further characterized by de-
termining whether they express Myf5 mRNA. In agreement 
with the results of Kiefer and Hauschka (2001), Myf5 mRNA 
was not detected by in situ hybridization in the stage 1 or 2 epi-
blast (Fig. 1 E). The lack of detection of Myf5 mRNA in the 
pregastrulating epiblast suggests that MyoD is expressed before 
Myf5 in the chick embryo, although analyses of the embryo be-
fore laying would be required to demonstrate this defi  nitively. 
Myf5 mRNA was detected in only a subpopulation of G8
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in the stage 4 epiblast (Fig. 1 F). Interestingly, a few stage 4 
epiblast cells that did not appear to express the G8 antigen ex-
pressed Myf5 (Fig. 1 F). Therefore, epiblast cells of gastrulating 
embryos may be heterogeneous with respect to their expression 
of muscle regulatory factors.
Behavior of MyoD
pos epiblast cells tracked 
into the heart and nervous system
Cells expressing MyoD mRNA in the stage 2 epiblast were 
tracked into the heart and nervous system by fl  uorescently la-
beling them with the G8 mAb and incubating the embryos for 
3 d in ovo (stage 16). Although the majority of G8
pos cells were 
incorporated into the somites (56%),  9 labeled cells were 
found in the heart, 10 were found in the neural tube, 9 were in 
the brain, and 27 were found in other nonsomitic tissues of 
the embryo, including the mesenchyme of the head. Most were 
present as single cells surrounded by G8-negative (G8
neg) cells. 
Within the somites, all of the G8
pos cells contained MyoD pro-
tein (Fig. 2 A), and the majority (73%) had synthesized sarco-
meric myosin.
All of the G8
pos cells tracked into the heart continued to 
express MyoD mRNA, and a subpopulation (59%) was stained 
with the MyoD mAb (Fig. 2, B–D). Although most cells lacking 
the G8 label had synthesized cardiac troponin T, this marker for 
cardiac muscle differentiation was not detected in any G8
pos 
cells in the stage 16 heart (Fig. 2 E). Within the central nervous 
system (CNS) of the stage 16 embryo, all G8
pos cells that origi-
nated in the epiblast continued to express MyoD mRNA, and 
 50% were stained with the MyoD mAb (Fig. 2, F and G). 
Only a single G8
pos cell contained sarcomeric myosin (Fig. 2 H). 
None of the G8
pos cells were labeled with an antibody to neuro-
fi  lament-associated antigen (Fig. 2 I).
The CNS (Fig. 2 J) and heart contained a few cells that ex-
pressed MyoD but lacked the G8 tag that had been applied in the 
stage 2 embryo. This is consistent with the observation that more 
G8
pos cells ( 36 cells) were found in hearts directly labeled with 
the G8 mAb than the number of G8
pos epiblast cells tracked into 
the heart (nine cells). Some cells with MyoD mRNA but lack-
ing the G8 tag applied in the epiblast were present in clusters 
containing G8-labeled cells, whereas others were surrounded by 
G8
neg cells (Fig. 2 J). Although it is possible that the G8 signal 
was lost in some cells as a result of proliferation, the expression 
of MyoD may have been initiated in a separate population after 
application of the antibody (Gerhart et al., 2006).
Importantly, no cell that expressed MyoD mRNA and the 
G8 antigen within the epiblast and were tracked into the heart 
or nervous system or any cells that may have initiated G8 syn-
thesis sometime after stage 2 of development contained detect-
able levels of cardiac troponin T or neurofi  lament-associated 
antigen. These results indicate that G8
pos epiblast cells are not 
Figure 1.  Expression of G8, MyoD, and Myf5 in 
the pregastrulating and gastrulating epiblast. Whole 
stage 1 and 4 embryos were double labeled for the 
G8 antigen (green) and MyoD mRNA (MyoD M), 
MyoD protein (MyoD P), or Myf5 mRNA (red). Nu-
clei were stained with Hoechst dye (blue). G8 and 
MyoD mRNA were expressed in the same cells in 
the stage 1 epiblast (arrows in A). The MyoD mAb 
did not label cells in the stage 1 epiblast or most 
cells of the stage 4 epiblast (arrowheads in B and D). 
One G8
pos cell in the stage 4 epiblast was stained 
with the MyoD mAb (arrow in C). Myf5 was not de-
tected in the stage 1 epiblast (arrowhead in E). The 
stage 4 epiblast contained subpopulations of G8
pos/
Myf5
neg, G8
pos/Myf5
pos (arrows), and G8
neg/Myf5
pos 
cells (arrowhead; F). Bar, 9 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  652
induced to differentiate into cardiac muscle or neurons in the 
developing heart and nervous system.
Microinjection of MyoD
pos and MyoD
neg 
epiblast cells into the precardiac mesoderm 
and neural plate
In the aforementioned tracking experiments, it is possible that the 
restriction of developmental potential may have occurred in cells 
on route to their fi  nal destination. Therefore, a second approach 
was taken to challenge the behavior of MyoD
pos epiblast cells that 
involved microinjecting them directly into the precardiac meso-
derm and neural plate. Stage 1 epiblasts were removed from the 
embryo, dissociated, labeled with the G8 mAb, and the G8
pos and 
G8
neg populations were isolated by magnetic cell sorting. The pu-
rity of both sorted populations was >97% (Gerhart et al., 2004a). 
Sorted cells were labeled with Hoechst dye, a procedure that did 
not affect their viability or ability to differentiate in vitro (unpub-
lished data). 60 G8
pos or G8
neg Hoechst-labeled epiblast cells were 
Figure 2.  Expression of skeletal muscle, cardiac muscle, and 
neuronal markers in G8
pos epiblast cells tracked into the heart 
and brain. Cells that expressed MyoD mRNA in the stage 2 
epiblast were labeled with the G8 mAb (green) and tracked 
into the somite, heart, and brain of the 3-d embryo. Sections 
were stained for MyoD mRNA (MyoD M), MyoD protein 
(MyoD P), cardiac troponin T (CTpn), or neuroﬁ  lament-associated 
antigen (NF; red). Nuclei were labeled with Hoechst dye (blue). 
Merged images with overlapping red and green ﬂ  uorescence 
appear white. G8
pos cells that stained with the MyoD mAb 
were concentrated in the somites (arrows in A). G8
pos cells of 
the heart and brain contained MyoD mRNA (arrows in B and F), 
and some were labeled with the MyoD mAb (arrows in D and G). 
G8
pos cells that were not labeled with the MyoD mAb are 
shown in C and G (arrowheads). Other G8
pos cells in these 
organs did stain with the MyoD mAb (arrows in D and G). 
The brain contained G8
pos/sarcomeric myosin
pos (arrow) and 
G8
pos/sarcomeric myosin
neg cells (arrowhead; H). Cardiac 
troponin T or neuroﬁ   lament-associated antigen was not 
detected in G8
pos cells in the heart and brain, respectively 
(arrowheads in E and I). MyoD mRNA was expressed in some 
G8
neg cells in the brain (arrowhead in J). Bar, 9 μm.STABLE COMMITMENT OF MYOD-POSITIVE EPIBLAST CELLS • GERHART ET AL. 653
microinjected into six sites (10 cells per site) of the precardiac 
mesoderm of stage 4–5 embryos (Fig. 3 A) or the neural plate of 
stage 6–7 embryos (Fig. 4 A). The microinjection procedure did 
not appear to affect morphogenesis of the heart or nervous system 
during the course of the experiment (Figs. 3, B and C; and 4, B–D). 
The expression of cell type–specifi  c markers was analyzed in tissue 
sections and after the dissociation of tissues and centrifugation of 
the cell suspensions onto slides.
Figure 3.  Expression of skeletal and cardiac muscle markers in G8
pos and G8
neg epiblast cells microinjected into the developing heart. G8
pos (G8+) and 
G8
neg (G8−) epiblast cells were labeled with Hoechst dye (blue) and microinjected into the precardiac mesoderm of the stage 4 embryo. (A) Microinjection 
sites (arrows) above and lateral to the primitive streak (PS) are shown in the photomicrograph of the area outlined in the inset. (B) Embryos developed nor-
mally after microinjection. (C) An enlargement of the heart containing G8
pos cells. (D–O) Sections were stained for markers of skeletal and cardiac muscle 
(red in E, G, I, K, M, and O). Cardiac troponin T was not detected in G8
pos cells (arrowheads in D and E). G8
pos cells expressed MyoD mRNA (arrows in 
F and G). Subpopulations of G8
pos/MyoD mAb
pos (arrows) and G8
pos/MyoD mAb
neg (arrowheads) were present in the heart (H and I). The 12101 marker 
of skeletal muscle differentiation was detected in some G8
pos cells (arrows in J and K) but not in others (arrowheads in J and K). G8
neg cells microinjected 
into the developing heart did not express MyoD mRNA (arrowheads in L and M). Instead, they differentiated into cardiac muscle (arrows in N and O). 
Bars (A and B), 56 μm; (C) 27 μm; (D–O) 9 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  654
Figure 4.  Expression of skeletal muscle and neuronal markers in G8
pos and G8
neg epiblast cells microinjected into the developing nervous system. G8
pos 
(G8+) and G8
neg (G8−) epiblast cells were labeled with Hoechst dye (blue) and microinjected into the neural plate of the stage 7 embryo. Microinjected 
cells are shown in the photomicrograph of the area outlined in the inset of A. Embryos were grown for 2.5 d. Areas outlined in B are shown at higher mag-
niﬁ  cation in C and D. The brain (C) and neural tube (NT; D) contained microinjected cells. Sections through the brain were stained with markers for skeletal 
muscle and neurons (red in F, H, J, L, N, and P). Neuroﬁ  lament-associated antigen (NF) was not detected in G8
pos cells (arrowheads in E and F). MyoD 
mRNA (MyoD M) was present in G8
pos cells in the brain (arrows in G and H). Some G8
pos cells stained with the MyoD mAb (MyoD P; arrows in I and J). 
A host cell lacking the G8 marker was positive for MyoD mRNA (arrowheads in G and H). A G8
pos cell expressing sarcomeric myosin is shown in K and L. 
G8
neg cells expressed neuroﬁ  lament-associated antigen (arrows in M and N) but not MyoD mRNA (arrowheads in O and P). Bars (A and B), 56 μm; 
(C and D) 27 μm; (E–P) 9 μm.
Behavior of MyoD
pos and MyoD
neg 
epiblast cells microinjected into 
the precardiac mesoderm
After microinjecting cells into the precardiac mesoderm of 
stage 4–5 embryos,  94% of the Hoechst-labeled cells were 
later found in stage 12–14 hearts (Fig. 3 C). Microinjected G8
pos 
cells increased in number to a greater extent than G8
neg cells 
(2.5- and 1.9-fold, respectively; P ≤ 0.05). Some clusters of two 
to four G8
pos cells were found within the myocardium, although 
most were present as single cells surrounded by host cells (Fig. 3, 
D–K). The majority of microinjected G8
neg cells was present 
within the middle of the myocardium (Fig. 3, L and M), whereas STABLE COMMITMENT OF MYOD-POSITIVE EPIBLAST CELLS • GERHART ET AL. 655
G8
pos epiblast cells often were found toward the periphery of the 
myocardium (Fig. 3, D–K), suggesting that some cell sorting 
may have occurred.
None of the Hoechst-labeled G8
pos cells contained detect-
able levels of cardiac troponin T (Fig. 3, D and E; and Table I). 
Instead, 99% contained MyoD mRNA (Fig. 3, F and G), and 
most were labeled with the MyoD mAb (Fig. 3, H and I; and 
Table I). Some of the microinjected G8
pos cells differentiated 
into skeletal muscle, as indicated by staining with the 12101 
mAb (Fig. 3, J and K), although the percentage of these cells 
that expressed 12101 in vivo varied greatly between experi-
ments (Table I). This may refl  ect a delay in the accumulation of 
this antigen after terminal differentiation because the majority 
of G8
pos cells contained sarcomeric myosin (Table I).
G8
pos epiblast cells microinjected into the precardiac me-
soderm displayed a greater tendency to differentiate into skele-
tal muscle than those that were tracked from the epiblast into 
the heart. This suggests that the procedure for isolating and 
dissociating the epiblast in preparation for sorting and micro-
injection may have enhanced the ability of MyoD
pos cells to 
differentiate in foreign environments. Cell–cell interactions 
within the epiblast epithelium and a factor produced in the me-
soderm are inhibitory for skeletal myogenesis (George-Weinstein 
et al., 1996).
The procedure for isolating epiblast cells is not suffi  cient 
to trigger skeletal myogenesis in epiblast cells that lack MyoD 
mRNA. Less than 1% of microinjected G8
neg cells or their prog-
eny contained detectable levels of MyoD mRNA (Fig. 3, L and M) 
or MyoD protein, and none appeared to synthesize the 12101 
antigen (Table I). Unlike the G8
pos cells, nearly all of the G8
neg 
cells that were microinjected into the precardiac mesoderm dif-
ferentiated into cardiomyocytes (Fig. 3, N and O; and Table I). 
A greater percentage of G8
neg epiblast cells were labeled with 
the cardiac troponin antibody than host cells (P ≤ 0.03), illus-
trating their proclivity for differentiation.
A small decrease was found in the number of host cells 
that differentiated into cardiac muscle in embryos microinjected 
with G8
pos cells than G8
neg cells (Table I). Slightly more host 
cells were stained with mAbs to MyoD and 12101 in hearts im-
planted with G8
pos cells than G8
neg cells (Table I). This raises the 
possibility that microinjected G8
pos cells infl  uence the pathway 
of the differentiation of host cells in the heart. The results ob-
tained when epiblast cells were microinjected into the develop-
ing heart were consistent with the cell-tracking experiments. 
That is, cells expressing MyoD mRNA in the epiblast continued 
to do so in the heart and were not redirected to the cardiac mus-
cle lineage. In contrast, cells that lacked MyoD mRNA in the 
epiblast were capable of differentiating into cardiac muscle.
Behavior of G8
pos and G8
neg cells 
microinjected into the neural plate
The fate of epiblast cells that express MyoD mRNA was also 
tested in the developing nervous system. As was the case with 
implantations into the heart, the microinjected G8
pos cells in-
creased in number to a greater extent than G8
neg cells (10-fold 
and ninefold, respectively). The higher rates of proliferation of 
cells microinjected into the neural plate than in the precardiac 
mesoderm is consistent with the observation that cardiomyo-
cyte differentiation was nearly complete by the time the embryos 
were fi  xed for analysis (Manasek, 1968).
Greater than 80% of the microinjected cells were found in 
the head (Fig. 4 C). Within the head, 75% of Hoechst-labeled 
cells were present in the brain. Approximately 60% of the 
Hoechst-labeled cells in the trunk were found in the neural tube 
(Fig. 4 D). Most of the microinjected cells were surrounded by 
host cells, although some were present in clusters of two to four 
cells in the brain and neural tube (Fig. 4, E–P).
Neurofi  lament-associated antigen was not detected in any 
of the G8
pos cells microinjected into the neural plate even when 
they were surrounded by host cells containing this marker of 
neuronal differentiation (Fig. 4, E and F; and Table II). Instead, 
all G8
pos cells found within the CNS (Fig. 4, G and H) and other 
embryonic tissues contained MyoD mRNA. Within the CNS, 
some G8
pos cells were labeled with mAbs to MyoD protein 
( 70%; Fig. 4, I and J), sarcomeric myosin ( 13%; Fig. 4, 
K and L), and the 12101 antigen ( 7%). The majority ( 55%) 
of Hoechst-labeled G8
pos cells present in the mesenchyme of the 
head or myogenic region of the somite had differentiated into 
skeletal muscle. A few host cells were found to express MyoD 
mRNA in the brain (Fig. 4, G and H).
In contrast to the behavior of G8
pos cells,  70% of G8
neg 
cells that were microinjected into the neural plate and incorpo-
rated into nervous tissue expressed neurofi  lament-associated 
antigen (Fig. 4, M and N). Only 1% of the Hoechst-labeled 
G8
neg cells contained MyoD mRNA (Fig. 4, O and P), and none 
were stained with mAbs to MyoD protein or the 12101 antigen. 
All Hoechst-labeled G8
neg cells found in the myogenic region of 
the somite did express MyoD mRNA (unpublished data).
Table I. Differentiation of G8
pos and G8
neg cells microinjected into the precardiac mesoderm
Percent positive
Myosin 12101 MyoD CTpn
G8
pos cells 87 ± 11 (8) 40 ± 36 (8) 73 ± 13 (7) 0 (7)
Host cells 77 ± 16 (8) 1 ± 2 (8) 2 ± 1 (7) 82 ± 25 (8)
G8
neg cells 92 ± 9 (9) 0 (8) 0.4 ± 1 (7) 95 ± 8 (8)
Host cells 86 ± 10 (9) 0.4 ± 1 (9) 1 ± 1 (7) 88 ± 6 (8)
G8
pos and G8
neg cells were isolated from the stage 1 epiblast, labeled with Hoechst dye, and microinjected into the precardiac mesoderm of stage 4–5 embryos. 
Embryos were grown to stages 12–13 in culture. Hearts were removed and dissociated, and the cells were centrifuged onto slides. Cells were stained with mAbs to 
sarcomeric myosin, the skeletal muscle–speciﬁ  c 12101 antigen, MyoD, and cardiac muscle–speciﬁ  c troponin T (CTpn). More than 200 cells were scored per slide. 
The results are given as the mean ± SD. The number of slides scored is indicated in parentheses. G8
pos cells expressed markers of the skeletal muscle lineage and did 
not differentiate into cardiac muscle. G8
neg cells underwent cardiomyogenesis.JCB • VOLUME 178 • NUMBER 4 • 2007  656
A precise determination of the percentages of cells micro-
injected into the neural plate that later differentiated into neu-
rons or skeletal muscle throughout the embryo was calculated 
by separating the head from the trunk, dissociating the tissues to 
produce a single-cell suspension, centrifuging the cells onto 
slides, and staining with antibodies (Table II). Signifi  cantly 
more Hoechst-labeled G8
pos than G8
neg cells were stained with 
the MyoD mAb (head, P ≤ 0.000005; trunk, P ≤ 0.0003) and 
differentiated into skeletal muscle (head, P ≤ 0.02). Impor-
tantly, no microinjected G8
pos epiblast cells were stained with 
the antibody to neurofi  lament-associated antigen, whereas ap-
proximately one third of the microinjected G8
neg cells in the 
head and 10% in the remainder of the embryo expressed this 
marker of neurogenesis.
The results of experiments involving the microinjection of 
epiblast cells into the neural plate were consistent with those in 
which cells were tracked into the nervous system. They also mir-
rored the data obtained when epiblast cells were microinjected or 
tracked into the heart. Regardless of whether MyoD
pos cells were 
incorporated into the nervous system or heart, they either re-
mained as skeletal muscle precursors or formed skeletal muscle. 
They did not differentiate into neurons or cardiac muscle.
Behavior of microinjected MyoD
pos epiblast 
cells in culture
Although G8
pos epiblast cells microinjected into the precardiac 
mesoderm and neural plate continued to express MyoD mRNA in 
the heart and nervous system, only a subpopulation synthesized 
sarcomeric myosin and the 12101 antigen. To test whether the 
population of microinjected G8
pos epiblast cells that remained un-
differentiated was capable of undergoing skeletal myogenesis, cell 
cultures were prepared from hearts, heads, and trunks. Because 
epiblast cells lacking MyoD mRNA in vivo do not form skeletal 
muscle in this culture system, the conditions are permissive and 
not instructive for skeletal myogenesis (Gerhart et al., 2004a; 
Strony et al., 2005). 4 d after plating, 90–100% of Hoechst-labeled 
G8
pos epiblast cells that had been microinjected into the embryo 
synthesized the 12101 antigen (90 ± 5% from the heart, 95 ± 4% 
from the head, and 100% from the trunk; n = 3 cultures per 
region; Fig. 5, A–C). Therefore, MyoD
pos epiblast cells micro-
injected into the precardiac mesoderm and neural plate are able to 
differentiate into skeletal muscle in a permissive environment.
Discussion
MyoD mRNA is expressed in a subpopulation of cells in the 
epiblast before the onset of gastrulation (George-Weinstein 
et al., 1996; Gerhart et al., 2000, 2006; Strony et al., 2005). When 
these cells are isolated from the stage 1 chick embryo and cul-
tured in serum-free medium, >95% differentiate into skeletal 
muscle (Gerhart et al., 2004a). In this study, we tested whether 
MyoD
pos epiblast cells are stably committed to the skeletal mus-
cle lineage by examining their behavior in environments that 
promote cardiomyogenesis and neurogenesis.
Cells expressing MyoD mRNA in the epiblast were either 
labeled in vivo and tracked into the heart and nervous system or 
isolated from stage 1 embryos and microinjected into the pre-
cardiac mesoderm and neural plate of gastrulating embryos. 
Both types of experiments revealed that MyoD
pos epiblast cells 
survived, proliferated, and continued to express MyoD in the 
heart and nervous system. A subpopulation of these cells differ-
entiated into skeletal muscle in these ectopic locations. Nearly 
all MyoD
pos epiblast cells that were microinjected into the heart 
and nervous system differentiated into skeletal muscle when 
placed in culture. These fi  ndings indicate that epiblast cells ex-
pressing MyoD mRNA but lacking detectable MyoD protein or 
mRNA for Myf5 (this study), myogenin, or sarcomeric myosin 
(George-Weinstein et al., 1996; Gerhart et al., 2000) are stably 
committed to the skeletal muscle lineage before the onset of 
gastrulation. Therefore, incorporation into the mesoderm and 
somites is not required for the specifi  cation and determination 
of this enigmatic population of skeletal muscle stem cells.
Most cells that do not express MyoD in the epiblast appear 
to be uncommitted and multipotent because they differentiate 
into either cardiac muscle or neurons when microinjected into 
the precardiac mesoderm or neural plate. Their proclivity for 
differentiating according to environmental signals was revealed 
within the context of a developing tissue. Multipotent stem cells 
Table II. Differentiation of G8
pos and G8
neg cells microinjected into the neural plate
Percent positive
Myosin 12101 MyoD Neuroﬁ  l.
Head
 G8
pos cells 35 ± 12 (8) 41 ± 27 (10) 70 ± 17 (8) 0 (8)
 Host  cells 9 ± 3 (8) 11 ± 1 (10) 15 ± 3 (8) 17 ± 2 (8)
 G8
neg cells 17 ± 8 (8) 19 ± 10 (10) 15 ± 9 (10) 32 ± 6 (8)
 Host  cells 15 ± 6 (8) 9 ± 3 (10) 13 ± 3 (10) 19 ± 3 (8)
Trunk and limbs
 G8
pos cells 29 ± 45 (8) 57 ± 21 (10) 91 ± 12 (10) 0 (8)
 Host  cells 37 ± 4 (8) 13 ± 3 (10) 20 ± 4 (10) 16 ± 3 (8)
 G8
neg cells 32 ± 33 (8) 40 ± 35 (11) 44 ± 30 (10) 27 ± 36 (8)
 Host  cells 41 ± 4 (8) 12 ± 6 (11) 29 ± 10 (10) 12 ± 6 (8)
G8
pos and G8
neg cells were isolated from stage 1 epiblasts, labeled with Hoechst dye, and microinjected into the neural plate of stage 6–7 embryos. Embryos were 
grown to stages 15–16 in culture. The heads were separated from the trunk, the tissues were dissociated, and the cells were centrifuged onto slides. Cells were stained 
with mAbs to sarcomeric myosin, the 12101 antigen, MyoD, and neuroﬁ  lament-associated antigen (Neuroﬁ  l). More than 200 cells were scored per slide. The results 
are the mean ± SD. The number of slides scored is indicated in parentheses. G8
pos cells expressed markers of the skeletal muscle lineage and did not differentiate 
into neurons. Subpopulations of G8
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used for tissue regeneration may not display the same ability 
to differentiate into the desired cell type because the environ-
ment within diseased tissues of the adult may lack the mole-
cules required for inducing specifi  cation, determination, and 
differentiation. Premixing multipotent cells with stably com-
mitted cells capable of producing factors that recruit unspeci-
fi  ed cells to the appropriate lineage may improve the effi  ciency 
of tissue regeneration.
Our cell-tracking experiments revealed that the majority 
of MyoD
pos epiblast cells were incorporated into the somites 
(Gerhart et al., 2006; and this study). Although many of these 
cells differentiated into skeletal muscle, some were retained in 
the dermomyotome region of the somite that contains replicat-
ing myogenic precursors. Therefore, MyoD
pos epiblast cells may 
undergo self-renewal and produce offspring that differentiate in 
the somite.
Some MyoD
pos epiblast cells were integrated in the heart, 
nervous system, and other structures. This observation is consis-
tent with the locations of MyoD
pos cells in the epiblast that corre-
spond to areas fated to give rise to somites as well as nonsomitic 
tissues (Gerhart et al., 2000). Given their location in the epiblast, 
it is likely that cells with MyoD mRNA followed similar routes 
to those taken by other epiblast cells destined for integration into 
the heart and nervous system. In this case, MyoD
pos cells would 
be exposed to factors that regulate early stages in the specifi  ca-
tion of cells to the cardiogenic or neurogenic lineages.
Specifi  cation of the nervous system begins before gastru-
lation in the central epiblast, as indicated by the expression of 
the preneural markers ENRI and SOX3; however, the defi  nitive 
neural marker SOX2 does not appear until neural plate forma-
tion (Streit et al., 2000; Wilson et al., 2000; Linker and Stern, 
2004; Stern, 2005). Specifi  cation of cardiomyocytes also be-
gins before the onset of gastrulation in the posterior epiblast 
(Yatskievych et al., 1997; Ladd et al., 1998), although the pro-
cess continues in an anterior to posterior direction in the primi-
tive heart (Linask and Lash, 1988; Linask et al., 1997). Exposure 
to early inducers of heart specifi  cation in the posterior epiblast 
may not be required for recruitment to the cardiomyocyte lin-
eage because >95% of MyoD
neg cells located throughout the 
epiblast differentiated into cardiac muscle when microinjected 
into the precardiac mesoderm.
We previously determined that small numbers of MyoD
pos 
cells are present in the heart, brain, and other organs of the 
fetal chicken (Gerhart et al., 2001). Ectopically located skel-
etal muscle precursors of the fetus may be the direct descen-
dants of MyoD
pos epiblast cells that were incorporated into all 
three germ layers during early stages of development. Murine 
embryos also contain ectopically located skeletal muscle pre-
cursors, as indicated by the expression of Myf5 in the ner-
vous system and the emergence of skeletal muscle in cultures 
prepared from mouse neural tubes (Tajbakhsh et al., 1994; 
Tajbakhsh and Buckingham, 1995). It remains to be determined 
whether precursor cells expressing MyoD survive in ectopic 
locations of the adult. If so, they may be capable of pro-
liferating in response to infl  ammatory cytokines and growth 
factors. Skeletal muscle precursors may be vulnerable to 
mutations leading to the development of rhabdomyosarcoma 
tumors, which often arise outside of skeletal muscle (Dagher 
and Helman, 1999).
MyoD
pos epiblast cells incorporated into seemingly ecto-
pic locations may be involved in the formation of nonskeletal 
muscle tissues by serving as a local source of a BMP inhibitor. 
Cells that express MyoD in the epiblast produce Noggin both 
inside and outside of the somites (Gerhart et al., 2006). Within 
the somites, the release of Noggin from MyoD
pos epiblast cells 
is critical for skeletal muscle differentiation (Gerhart et al., 
2006). Noggin derived from MyoD
pos epiblast cells also may be 
important for the development of other structures because abla-
tion of these cells in the epiblast results in facial and eye defects 
(Gerhart et al., 2006).
The population of MyoD
pos epiblast cells appears to be 
distinct from those cells that become committed to undergo 
myogenesis within the somites. Uncommitted myogenic pre-
cursors in the somites express Pax-3 and Pax-7 but not Myf5 
or MyoD (Goulding et al., 1994; Williams and Ordahl, 1994; 
Maroto et al., 1997; Tajbakhsh et al., 1997; Kassar-Duchossoy 
et al., 2005). Pax-3–positive precursor cells are present in the 
somites after MyoD
pos cells are ablated in the epiblast, and they 
differentiate in response to exogenous Noggin (Gerhart et al., 
2006). Therefore, myogenic precursors that arise in the somites 
do not appear to be the direct descendants of cells that express 
MyoD in the stage 2 epiblast.
Figure 5.  Differentiation of microinjected G8
pos epiblast cells in vitro. G8
pos cells were isolated from the stage 1 epiblast, labeled with Hoechst dye (blue), 
and microinjected into the stage 4 precardiac mesoderm and stage 7 neural plate. 2 d later, the hearts (A), heads (B), and trunks (C) were dissociated, 
and the cells were cultured for 5 d and stained with the 12101 mAb. Hoechst-labeled cells differentiated into skeletal muscle, whereas surrounding host 
cells were not stained with the 12101 mAb. Bar, 9 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  658
Another difference between MyoD
pos epiblast cells and the 
majority of myogenic precursors in the somite is that the latter 
express Myf5 before MyoD (Sassoon et al., 1989; Ott et al., 1991; 
Maroto et al., 1997; Hacker and Guthrie, 1998; Hirsinger et al., 
2001; Kiefer and Hauschka, 2001). In contrast, MyoD but not 
Myf5 mRNA is present in stage 1 and 2 chick embryos (Kiefer and 
Hauschka, 2001; and this study). By stage 3, only a subpopulation 
of epiblast cells with MyoD coexpresses Myf5 and vice versa.
In conclusion, the expression of MyoD mRNA in the pre-
gastrulating epiblast defi  nes a unique population of stem cells 
that are committed to the skeletal muscle lineage and are capa-
ble of self-renewing and differentiating. These cells promote 
the differentiation of a separate population of skeletal muscle 
precursors that arise within the mesoderm (Gerhart et al., 2006). 
MyoD
pos epiblast cells are also integrated into nonsomitic tis-
sues of the embryo. In these seemingly ectopic locations, they 
retain their identity as skeletal muscle stem cells (this study) 
and produce Noggin (Gerhart et al., 2006). Stable programming 
within the epiblast may ensure that MyoD
pos cells express simi-
lar regulatory molecules in a variety of environments.
Materials and methods
Double labeling of whole embryos
White Leghorn chick embryos (B E Eggs) were staged according to the 
method of Hamburger and Hamilton (1951). Three stage 1, four stage 2, 
four stage 3, and three stage 4 whole embryos were double labeled for the 
G8 antigen and MyoD protein. G8 is a cell surface antigen that is speciﬁ  -
cally expressed in epiblast cells that contain MyoD mRNA (Gerhart et al., 
2001, 2004a,b; Strony et al., 2005). Embryos were incubated with 35 μg 
G8 mAb diluted in 100 μl of 10% goat serum in PBS and goat anti–mouse 
IgM antibodies conjugated with AlexaFluor488 (Invitrogen) diluted 1:1,000 
in 10% goat serum in PBS. After permeabilizing with 0.5% Triton X-100, 
embryos were incubated with NCL-MyoD1 mAb to MyoD (Novacastra) 
diluted 1:1,000 and with goat anti–mouse IgG Fab′2 fragments conjugated 
with rhodamine (Jackson ImmunoResearch Laboratories) diluted 1:400 in 
10% goat serum in PBS. The NCL-MyoD1 mAb labels pectoralis skeletal 
muscle and G8
pos epiblast cells but not G8
neg epiblast cells, cardiac muscle, 
or ﬁ  broblasts in culture. This mAb also stains the dermomyotome, myotome, 
and small numbers of cells that express MyoD mRNA outside of the so-
mites in vivo. Stage 2 and 4 whole embryos also were labeled with the 
rabbit 6975B polyclonal antiserum to MyoD (a gift from S. Tapscott, Fred 
Hutchinson Cancer Research Center, Seattle, WA) and a goat anti–rabbit 
IgG conjugated with rhodamine (Chemicon). Nuclei were counterstained 
with 1 μg/ml of Hoechst dye in deionized water (Sigma-Aldrich) for 10 min. 
Labeling of embryos was performed at room temperature.
Three stage 1, two stage 2, two stage 3, and four stage 4 whole 
embryos were double labeled for the G8 antigen and Myf5 mRNA as 
described previously (Gerhart et al., 2001, 2004a,b; Strony et al., 2005). 
The G8 mAb was tagged with secondary antibodies conjugated with 
AlexaFluor488 as described in the previous paragraph. After permeabilizing 
in 0.1% Triton X-100 and 0.1% pepsin (Sigma-Aldrich), embryos were 
incubated in Cy3-labeled 3DNA dendrimers (Genisphere, Inc.) conjugated 
with an antisense cDNA sequence for chicken Myf5 mRNA (S53719; 
5′-A  T  A  T  A  G  T  G  G  A  T  G  G  C  A  G  A  G  C  T  G  A  G  G  A  T  T  T  C  G  -3′; Neville et al., 1992). 
Dendrimers lacking cDNAs for a speciﬁ  c mRNA were used as a nega-
tive control for background ﬂ  uorescence. Nuclei were counterstained with 
Hoechst dye as described in the previous paragraph.
Embryos were mounted in Gelmount (Biomeda) and observed with 
an epiﬂ  uorescence microscope (Eclipse E800; Nikon) equipped with the 
following ﬁ  lters: excitation at 530–560 nm and barrier at 573–648 nm for 
Cy3 and rhodamine; excitation at 465–495 nm and barrier at 515–555 nm 
for AlexaFluor488; and excitation at 330–380 nm and barrier at 435–
485 nm for Hoechst dye using 4× NA 0.2 and 60× NA 1.4 oil objectives 
(Nikon). Photomicrographs were produced with a video camera (Evolution 
QE; Media Cybernetics) and Image-Pro Plus image analysis software 
(Phase 3 Imaging Systems). Figures were annotated and adjusted for con-
trast and brightness in Photoshop 6.0 (Adobe).
Tracking MyoD
pos epiblast cells in the embryo
The tracking of MyoD
pos epiblast cells was performed as described previ-
ously (Gerhart et al., 2006). In brief, stage 2 embryos were removed from 
the shell on the yolk and incubated for 45 min at room temperature in 35 μg 
G8 mAb/100 μl HBSS (Invitrogen) and rinsed three times in PBS. 100 μl of 
secondary antibodies conjugated with rhodamine diluted 1:400 in Hanks 
buffer or AlexaFluor488 diluted 1:1,000 in Hanks buffer was added for 
45 min, and the embryos were rinsed three times in PBS. Labeled embryos still 
on the yolk were placed in an empty shell, incubated at 37°C, ﬁ  xed in form-
aldehyde, embedded in parafﬁ  n, and sectioned transversely at 10 μm.
Parafﬁ  n sections were labeled with mAbs to sarcomeric myosin 
heavy chain (MF20 mAb diluted 1:60; Bader et al., 1982), the skeletal 
muscle–speciﬁ  c 12101 antigen (12101 mAb diluted 1:10; Kintner and 
Brockes, 1984), neuroﬁ   lament-associated antigen (3A10 mAb diluted 
1:400; Furley et al., 1990), MyoD1 (NCL-MyoD1 diluted 1:150), or car-
diac troponin T (AB-1 mAb diluted 1:400; Neomarkers). The 12101 mAb 
stained skeletal muscle in cultures of pectoralis muscle and G8
pos epiblast 
cells and in sections through the myotomes and limbs. 12101 did not stain 
cardiac muscle in vivo or in vitro. The cardiac troponin T mAb labeled car-
diac muscle in culture and in sections through the heart but did not stain 
skeletal muscle in sections through the somites and limbs or cultures of pec-
toralis muscle or G8
pos epiblast cells (Gerhart et al., 2004a).
Primary antibodies were labeled with secondary antibodies con-
jugated with rhodamine or AlexaFluor488. All antibodies were diluted 
in 10% goat serum in PBS. The MF20, 12101, and 3A10 mAbs were 
obtained from the Developmental Studies Hybridoma Bank. Most sections 
were double labeled with antibodies and Cy3-labeled dendrimers conju-
gated with an antisense oligonucleotide sequence to chicken MyoD (5′-T  T  C  T-
C  A  A  G  A  G  C  A  A  A  T  A  C  T  C  A  C  C  A  T  T  T  G  G  T  G  A  T  T  C  C  G  T  G  T  A  G  T  A  -3′ [L34006; 
Dechesne et al., 1994]). Nuclei were counterstained with Hoechst dye. 
The sites of incorporation of G8
pos epiblast cells were determined in two 
stage 16 embryos.
Microinjection of G8
pos and G8
neg epiblast cells
G8
pos and G8
neg cells were separated by magnetic cell sorting as described 
previously (Gerhart et al., 2004a; Strony et al., 2005) In brief, epiblasts 
were isolated from the stage 1 embryo, dissociated in 0.25% trypsin-EDTA 
(Invitrogen) for 10 min, incubated with the G8 mAb for 45 min, and 
labeled with rat anti–mouse IgM microbeads (Miltenyi Biotec). Nuclei were 
counterstained with 1 μg Hoechst dye/ml Hanks buffer. Sorting of G8
pos 
and G8
neg cells was performed in a MiniMACS column (Miltenyi Biotec). 
After centrifugation, cells were resuspended in PBS (1,000 cells/μl). 2 μl 
of fast green solution (0.1 μl of fast green/μl of 70% glycerol; both were 
obtained from Sigma-Aldrich) was added to the cell suspension.
Embryos were rinsed in Hanks buffer and placed on nucleopore 
ﬁ  lters. Microinjections were performed with a microinjector (Nanoject II; 
Drummond Scientiﬁ  c). 10 cells were microinjected into each of six sites in 
the precardiac mesoderm (Fig. 3 A). Bilateral injections were made just 
above the rostral end of the head process, lateral to the head process, and 
lateral to the rostral end of the primitive streak. Implantations into the neu-
ral plate of stage 6–7 embryos consisted of six microinjections along the 
midline of the developing neural folds above the rostral end of the primitive 
streak (Fig. 4 A). Embryos on the nucleopore ﬁ  lters were transferred to 
nine-well 2.5-cm plates containing thin egg albumen and a piece of ash-
less ﬁ  lter paper (Whatman) with a hole cut in its center. The nine-well plate 
was placed in a Petri dish on ﬁ  lter paper moistened with PBS and incu-
bated at 37°C with 5% CO2 for 48 h.
Embryos receiving microinjections into the precardiac mesoderm 
(two embryos with G8
pos cells and two embryos with G8
neg cells) were 
ﬁ  xed at stages 12–14, embedded in parafﬁ  n, and serially sectioned. Em-
bryos that were microinjected into the neural plate (two embryos with 
G8
pos cells and two embryos with G8
neg cells) were ﬁ  xed at stages 15–16. 
Sections were labeled with dendrimers to MyoD mRNA and/or mAbs to 
MyoD, MF20, 12101, cardiac troponin T, or 3A10 as described above 
(see Double labeling of whole embryos).
Other embryos receiving microinjections into the precardiac meso-
derm had their hearts removed and were dissociated in 0.25% trypsin-
EDTA (Sigma-Aldrich) for 10 min to produce a single-cell suspension. 
Embryos that were microinjected in the neural plate were cut to separate 
the head from the trunk. The heart was then removed from the trunk so that 
analyses of myosin expression would reﬂ   ect skeletal and not cardiac 
muscle. Heads and trunks were also dissociated in trypsin-EDTA. Cells 
were ﬁ  xed in formaldehyde, centrifuged onto gelatin-coated glass slides 
for 4 min in a Cytofuge 2 centrifuge (Statspin), and stained with antibodies 
as described above (see Double labeling of whole embryos).STABLE COMMITMENT OF MYOD-POSITIVE EPIBLAST CELLS • GERHART ET AL. 659
Hearts were obtained from seven stage 10–14 embryos that re-
ceived microinjections of G8
pos or G8
neg cells into the precardiac mesoderm 
(three experiments; two to three hearts pooled per experiment). Head and 
trunk cells were obtained from seven stage 15–17 embryos that received 
microinjections into the neural plate (two experiments; three to four embryos 
pooled per experiment). A t test was used to compare populations.
Cell culture
2 d after Hoechst-labeled G8
pos and G8
neg stage 1 epiblast cells were 
microinjected into the precardiac mesoderm or neural plate, the hearts, 
heads, and trunks from two embryos were dissociated in trypsin-EDTA. 
Cells were plated at a density of 20,000/15 μl of medium on gelatin- and 
ﬁ  bronectin-coated dishes as described previously (George-Weinstein et al., 
1994, 1996). Dishes were ﬂ   ooded with 1.5 ml DME/F12 (Invitrogen). 
Cells were ﬁ  xed in 2% formaldehyde after 4 d in culture and stained with 
the 12101 mAb.
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